Immediate Impact

2 from Science/Nature 62 standout
Sub-graph 1 of 24

Citing Papers

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment
2022 Standout
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
2021 Standout
2 intermediate papers

Works of C. Hennequin being referenced

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer
2015
Séquelles radio-induites et tests prédictifs
2008

Author Peers

Author Last Decade Papers Cites
C. Hennequin 270 240 219 71 693
Tushar Vora 291 164 160 85 736
Nil Molinas Mandel 289 280 165 73 830
Tsai-Wang Huang 302 100 197 74 592
Carmen Rubio 184 223 165 73 645
Anne Olland 395 207 346 68 709
Chuang‐Chi Liaw 222 310 244 59 783
Raymond L. Chai 215 216 305 66 820
Theera Umsawasdi 434 562 55 41 824
Yoji Iwasaki 266 208 417 63 763
Tomonori Mizutani 493 183 182 54 778

All Works

Loading papers...

Rankless by CCL
2026